文献速递临床生化临床免疫

血清ASC蛋白:一种新型卒中生物标志物

Serum apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC) is a novel stroke biomarker.
PubMed 文献 · Clin Chim Acta · 2023-12-20

该研究纳入774例中国卒中患者(523例缺血性卒中、251例出血性卒中)及481例健康对照和64例认知障碍对照,采用自动化化学发光免疫分析法检测血清ASC浓度。结果显示卒中患者ASC浓度显著高于所有对照(P < 0.001),出血性卒中高于缺血性卒中(P < 0.05),且ASC浓度越高重症比例越高;超急性期区分健康人与卒中患者的AUC为0.78,在健康人与蛛网膜下腔出血≤3小时样本中AUC提升至0.90。

要点

  • 卒中患者血清ASC浓度显著高于健康及认知障碍对照(P < 0.001)。
  • 出血性卒中ASC浓度高于缺血性卒中(P < 0.05),且浓度越高重症比例越高。
  • 超急性期区分健康人与卒中AUC为0.78,SAH≤3小时样本中达0.90。

核心结论

  • 血清ASC是用于卒中鉴别诊断的有价值生物标志物,有助于临床判断卒中严重程度和亚型。

研究设计与样本

  • 研究纳入774例中国卒中患者(523例缺血性卒中、251例出血性卒中,症状发作14天内于急诊科招募),以及481例健康对照和64例认知障碍对照。
  • 采用自动化化学发光免疫分析法测定血清ASC浓度,分析其与卒中亚型、严重程度及采样时间点的关系。

主要发现

  • 卒中患者ASC浓度显著高于所有对照(P < 0.001)。
  • 出血性卒中患者ASC浓度高于缺血性卒中患者(P < 0.05)。
  • 随着ASC浓度升高,重症病例比例增加。
  • 区分健康人与超急性期卒中患者的AUC为0.78;在健康人与蛛网膜下腔出血≤3小时(自最后已知健康时间起)样本中AUC为0.90。

关键数值与推荐

  • 超急性期区分健康人与卒中患者AUC为0.78。
  • 健康人与蛛网膜下腔出血≤3小时样本中AUC为0.90。

临床怎么用

  • 血清ASC可作为卒中鉴别诊断的辅助生物标志物,帮助判断卒中严重程度和亚型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC) is a promising stroke biomarker. However, a large study of human serum ASC has not yet to be reported; additionally, the diagnostic value of prehospital concentration and practicality of ASC remains unknown. METHODS: We recruited 774 Chinese stroke patients, including 523 with ischemic stroke (IS) and 251 with hemorrhagic stroke (HS) within 14 days following symptom onset in the emergency department, alongside 481 healthy individuals and 64 cognitive impairment patients as controls. Serum ASC concentrations were determined using automated chemiluminescence immunoassay, exploring the relationship between serum ASC concentration and subtypes, severity, and sampling timepoints of stroke. RESULTS: ASC concentrations were significantly higher in stroke patients compared with all controls (P < 0.001). HS patients had greater ASC concentrations than IS patients (P < 0.05). With increasing ASC concentration, the proportion of severe cases increased. The area under the receiver operating characteristic curve (AUC) for differentiating between healthy individuals and stroke patients in the hyperacute phase was 0.78; this markedly improved (0.90) when considering samples from healthy individuals and patients with subarachnoid hemorrhage (SAH) ≤ 3 h from last-known-well (LKW). CONCLUSIONS: Serum ASC is a valuable biomarker for stroke differentiation and aids in the clinical diagnosis of stroke severity and subtypes.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Luan X, Li G, Ding Y, et al. Serum apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC) is a novel stroke biomarker. Clin Chim Acta. 2023. PMID: 38128818. doi:10.1016/j.cca.2023.117734

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。